Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 3, 2007, Pages 438-444

  Yoshida, Kana ^a,b   Osawa, Kayo ^a   Kasahara, Mayumi ^a   Miyaishi, Aiko ^c   Nakanishi, Keiko ^d   Hayamizu, Saori ^b   Osawa, Yasunori ^a   Tsutou, Akimitsu ^a   Tabuchi, Yoshiki ^e   Shimada, Etsuji ^f   Tanaka, Kenichi ^g   Yamamoto, Masahiro ^h   Takahashi, Juro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Cancer Immuno Chemotherapy Center   (Japan)

^c Otemae Hospital   (Japan)

^d FALCO Biosystems Ltd   (Japan)

^e Yoshida Ardent Hospital   (Japan)

^f Graduate School of Health Sciences   (Japan)

^g YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^h KOBE ROSAI HOSPITAL   (Japan)

Author keywords

Colorectal cancer; CYP1A1; CYP1A2; Gene polymorphism; GSTM1; NAT2

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; NAT2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

AGED; ARTICLE; ASIAN; CASE CONTROL STUDY; COLORECTAL TUMOR; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; JAPAN; MALE; MIDDLE AGED; RISK; SMOKING;

AGED; ARYLAMINE N-ACETYLTRANSFERASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; SMOKING;

EID: 44449086554     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abe M, Suzuki T, Deguchi T (1993). An improved method for genotyping of N-acetyltransferase polymorphism by polymerase chain reaction. Jpn J Human Genet, 38, 163-8.
2. Chen J, Stampfer MJ, Hough HL, et al (1998). A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res, 58, 3307-11.
3. Christiansen L, Bygum A, Jensen A, et al (2000). Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Hum Genet, 107, 612-4.
4. Comstock KE, Sanderson BJ, Claflin G, et al (1990). GST1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res, 18, 3670.
5. Cotton SC, Sharp L, Little J, et al (2000). Glutathione Stransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol, 151, 7-32.
6. Giovannucci E (2001). An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 10, 725-31.
7. Hayashi S, Watanabe J, Nakachi K, et al (1991). Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J Biochem, 110, 407-11.
8. Hein DW (1988). Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta, 948, 37-66.
9. Hein DW (2002). Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res, 506-7, 65-77.
10. Huang K, Sandler RS, Millikan RC, et al (2006). GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer Causes Control, 17, 385-94.
11. Kawajiri K, Nakachi K, Imai K, et al (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett, 263, 131-3.
12. Lang NP, Butler MA, Massengill J, et al (1994). Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev, 3, 675-82.
13. Le Marchand L, Hankin JH, Wilkens LR, et al (2001). Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 10, 1259-66.
14. Little J, Sharp L, Masson LF, et al (2006). Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer, 119, 2155-64.
15. MacLeod SL, Tang Y-M, Yokoi T, et al (1998). The role of a recently discovered genetic polymorphism in the regulation of the human CYP1A2 gene. Proc Am Assoc Cancer Res, 39,396.
16. Moonen H, Engels L, Kleinjans J, et al (2005). The CYP1A2- 164A_C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans. Cancer Lett, 229, 25-31.
17. Nakajima M, Yokoi T, Mizutani M, et al (1999). Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem, 125, 803-8.
18. Osawa Y, Osawa K, Miyaishi A, et al (2007). NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status. Asian Pac J Cancer Prev, 8,103-8.
19. Pisani P, Mitton N (2002). Cooking methods, metabolic polymorphisms and colorectal cancer. Eur J Cancer Prev, 11, 75-84.
20. Sachse C, Brockmoller J, Bauer S et al (1999). Functional significance of a C_A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol, 47, 445-9.
21. Sachse C, Smith G, Wilkie MJ, et al (2002). A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis, 23, 1839-49.
22. Sachse C, Bhambra U, Smith G, et al (2003). Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol, 55, 68-76.
23. Sivaraman L, Leatham MP, Yee J, et al (1994). CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res, 54, 3692-5.
24. Slattery ML, Samowtiz W, Ma K, et al (2004). CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol, 160, 842-52.
25. Sugimura T (2000). Nutrition and dietary carcinogens. Carcinogenesis, 21, 387-95.
26. Tsuchiya Y, Sato T, Kiyohara C, et al (2002). Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer. J Exp Clin Cancer Res, 21,119-24.